No GMP. I Think this issue will open at discount. If u look at the trackrecord of Guiness Not much listing on same day.it has gone at discount and some issues are have gone up after discount. No need to apply no QIB/Corporate and HNIs have aplly very less. Retail is more. This will sure shot go down. Open up in discount.
i review his website and director his self is not having any back of medical knowledge and he is director of pharmasutical company, hup not so good , company director should have study back similar, i am not going ....sorry
Hyyy miss you given a your view on the director.i also checked him profile he studied civil engineering.if you don''t mind you able to check the director of sunpharma what his study then you have a wideview about the director need study about the segment. Let me explain dilip sangvi is director & founder of sunpharma.he study is b.com....and now sunpharma is no-1 pharma company in India. My moral is not to prove your analysis wrongs but there is the need of skill of directors this is more important than his education to company.
Good top line and bottom line growth. Capacity underutilised yet. Looking for tie-ups and expansion. Great return ratios. The issues seems to be reasonably priced when compared to peers. Having said that the company is actually facing a major working capital crunch. Major risk would be if due to any reason if the company under performs even in a couple of quarters going forward, it will be in trouble. Still unsure if worth taking the risk.